Incyte acquired Vega Therapeutics to diversify its late-stage pipeline.

1 report, 1 independent Updated Jul 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Incyte

Keep exploring

Part of

Biotech M&A speculation involving Incyte, AbbVie, and Viking Therapeutics, with three Nasdaq-listed names under watch. All 1 developments

The entities involved

Incyte
American pharmaceutical company
- Incyte, a biotech company based in Wilmington, outperformed the biotech ETF.Thu 13:11
- Incyte is presenting data at the European Academy of Dermatology and Venereology (EADV) conference held in Vienna.Tue 13:24

Coverage

Newest first; wire copies grouped

Jul 8yahoo.com